|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2008-4-21
|
|
pubmed:abstractText |
We aimed to test the maternal and fetal outcome of SLE patients who suffered from recurrent spontaneous abortion (RSA) treated with intravenous immunoglobulin (IVIg) alone during pregnancy and whether the clinical response to IVIg treatment is accompanied by modifications of SLE-associated antibodies and of complement levels.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anticardiolipin,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Complement C3,
http://linkedlifedata.com/resource/pubmed/chemical/Complement C4,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins, Intravenous,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone,
http://linkedlifedata.com/resource/pubmed/chemical/SS-A antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/SS-B antibodies
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1462-0332
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
646-51
|
|
pubmed:dateRevised |
2008-10-14
|
|
pubmed:meshHeading |
pubmed-meshheading:18346976-Abortion, Habitual,
pubmed-meshheading:18346976-Adult,
pubmed-meshheading:18346976-Analysis of Variance,
pubmed-meshheading:18346976-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:18346976-Antibodies, Anticardiolipin,
pubmed-meshheading:18346976-Antibodies, Antinuclear,
pubmed-meshheading:18346976-Aspirin,
pubmed-meshheading:18346976-Autoantibodies,
pubmed-meshheading:18346976-Complement C3,
pubmed-meshheading:18346976-Complement C4,
pubmed-meshheading:18346976-DNA,
pubmed-meshheading:18346976-Female,
pubmed-meshheading:18346976-Humans,
pubmed-meshheading:18346976-Immunization, Passive,
pubmed-meshheading:18346976-Immunoglobulins, Intravenous,
pubmed-meshheading:18346976-Immunosuppressive Agents,
pubmed-meshheading:18346976-Lupus Erythematosus, Systemic,
pubmed-meshheading:18346976-Prednisolone,
pubmed-meshheading:18346976-Pregnancy,
pubmed-meshheading:18346976-Pregnancy Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
|
|
pubmed:affiliation |
Department of Rheumatology, University of Rome Tor Vergata, 00133 Rome, Italy. roberto.perricone@uniroma2.it
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
